- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01971216
Mother-infant Signalling During Breastfeeding (MOMS)
Mother-infant Signalling During Breastfeeding: A Randomised Trial Investigating the Effects of a Relaxation Intervention in Breastfeeding Mothers on Breast Milk Production, Breast Milk Cortisol and Infant Behaviour and Growth.
Primary hypotheses
1. The use of a relaxation tape by breastfeeding mothers that will be given starting at week 2 postpartum, will result in : i) reduced maternal stress and anxiety ii) the production of a higher volume of breast milk iii) lower milk cortisol concentrations iv) favourable effects on infant behaviour (less crying, more sleeping) v) higher milk intake by the infant vi) more optimal growth, specifically higher lean mass and lower fat mass (body composition)
Secondary hypotheses (i) Infant temperament/behaviour and gender influence milk and energy intake and hence early growth and body composition (ii) Non-nutrient factors in breast milk (hormones including ghrelin and leptin) influence infant behaviour and feeding patterns and hence infant growth and body composition.
Studieoversikt
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
Kuala Lumpur, Malaysia
- Faculty of Medicine and Health Science, Universiti Putra Malaysia (UPM).
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
Primiparous mother with singleton pregnancy Infant is singleton and born at term (37-42 week of gestation) Infant birth weight of >2500 g (5,5 pounds or 5 pounds and 8,2 ounces) Mother and infant are generally healthy (free of serious illness that can affect breastfeeding or nursing infant, or energy balance of the infant).
No current or recent involvement in other research studies that could potentially affect any of outcome measures.
Mother speaks and understands either English only or English and Malay (some questionnaires are in English)
Exclusion Criteria:
Mother or baby has a major illness that affects nursing or breastfeeding, or affects energy balance of the infant.
Mother smokes Mothers who do not exclusively breastfeed their infant
-
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Annen
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Ingen inngripen: Control
Breastfeeding mothers who are not randomised to relaxation intervention
|
|
Eksperimentell: Relaxation
Breastfeeding mothers randomised to use relaxation tape at 2 weeks post-partum
|
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Maternal stress and anxiety
Tidsramme: Baselibne to 12 weeks
|
Maternal stress and anxiety assessed using the Cohen's Perceived Stress Scale (PSS) and Beck Anxiety Inventory (BAI) respectively (change in score from baseline to end-point at 12 weeks)
|
Baselibne to 12 weeks
|
Breast milk volume at 12 weeks assessed non-invasively using stable isotope techniques
Tidsramme: 12 weeks
|
Breast milk volume at 12 weeks assessed non-invasively using stable isotope techniques
|
12 weeks
|
Breast milk cortisol concentrations at 12 weeks
Tidsramme: 12 weeks
|
12 weeks
|
|
Infant behaviour measured using a 3-day diary at 12 weeks
Tidsramme: 12 weeks
|
12 weeks
|
|
Infant weight and body composition measured using stable isotopes at 12 weeks
Tidsramme: 12 weeks
|
12 weeks
|
|
Physiological changes (maternal saliva cortisol, breast milk cortisol and milk volume) before and after physiological-mini test in intervention group at 2,6 and 12 weeks.
Tidsramme: 2,6,12 weeks
|
2,6,12 weeks
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
---|---|
Non-nutrient factors in breast milk - leptin and ghrelin
Tidsramme: 2,6,12 weeks
|
2,6,12 weeks
|
Macronutrient composition of breast milk (fat and protein)
Tidsramme: 2,6,12 weeks
|
2,6,12 weeks
|
Andre resultatmål
Resultatmål |
Tidsramme |
---|---|
Infant temperament measured using the Rothbart questionnaire
Tidsramme: 12 weeks
|
12 weeks
|
Infant appetite assessed using the BEBQ
Tidsramme: 2,6,12 weeks
|
2,6,12 weeks
|
Maternal depression assessed using Edinburgh Postnatal Depression Scale (EPDS)
Tidsramme: 2 weeks
|
2 weeks
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Mary Fewtrell, MD, UCL Institute of Child Health, London
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Mohd Shukri NH, Wells J, Eaton S, Mukhtar F, Petelin A, Jenko-Praznikar Z, Fewtrell M. Randomized controlled trial investigating the effects of a breastfeeding relaxation intervention on maternal psychological state, breast milk outcomes, and infant behavior and growth. Am J Clin Nutr. 2019 Jul 1;110(1):121-130. doi: 10.1093/ajcn/nqz033.
- Shukri NHM, Wells J, Mukhtar F, Lee MHS, Fewtrell M. Study protocol: An investigation of mother-infant signalling during breastfeeding using a randomised trial to test the effectiveness of breastfeeding relaxation therapy on maternal psychological state, breast milk production and infant behaviour and growth. Int Breastfeed J. 2017 Jul 14;12:33. doi: 10.1186/s13006-017-0124-y. eCollection 2017.
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- 13NT05
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Avslapning
-
Trinitas Comprehensive Cancer CenterAptium Oncology Research NetworkUkjent
-
Chiang Mai UniversityFullførtHetetokter | Søvnforstyrrelser | NattesvetteThailand
-
University of California, San FranciscoFullført
-
Gadjah Mada UniversityTaipei Medical UniversityFullførtSmerte | Angst | Blodtrykk | Følelse av mestringsevne | Komfort | PulsIndonesia
-
Dana-Farber Cancer InstituteFullførtMonoklonal gammopati av ubestemt betydning | Ulmende myelomatoseForente stater
-
Massachusetts General HospitalThe Children's Tumor FoundationFullførtNevrofibromatose | Nevrofibromatose 2 | Schwannomatose | Nevrofibromatose IForente stater
-
Massachusetts General HospitalUkjentSmerte | Kronisk smerte | Fysisk aktivitetForente stater
-
University of JordanFullført
-
Massachusetts General HospitalNational Center for Complementary and Integrative Health (NCCIH)FullførtResiliens, psykologiskForente stater
-
Eduardo Fonseca PedreroPsicofundación: Fundación Española para Promoción, Desarrollo Científico... og andre samarbeidspartnereRekrutteringDepressiv lidelse | Emosjonell lidelse | Angstlidelse | Følelsesmessig problemSpania